— Know what they know.
Not Investment Advice

LIFS OTC

Life Stem Genetics Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: -50.0% 1Y: +0.0% 3Y: -98.3% 5Y: -97.8%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 47 · $4584 mcap · 19M float · 0.011% daily turnover · Short 67% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000099999997-0.000300000014
Volume4,490
Avg Volume2,169
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOGloria Simov
SectorHealthcare
IndustryBiotechnology
IPO Date2013-10-22
3300 Parker Lane
East Stroudsburg, PA 18301
US
+1 310 820 4400
About Life Stem Genetics Inc.

Life Stem Genetics Inc., an enterprise currently in its development phase, is focused on establishing a global network of clinics that specialize in stem cell therapy. Its comprehensive suite of offerings includes nutraceuticals, medical supplements, and intravenous nutritional cocktails, in addition to stem cell banking services. The company provides a variety of stem cell treatments addressing degenerative conditions, cancer, and weight management, alongside anti-aging and anti-viral therapies. Also available are Adistem stem cell treatments tailored for orthopedic, neurological, and lung diseases, as well as hyperbaric oxygen therapy. Life Stem Genetics Inc. maintains a strategic collaborative agreement with American CryoStem Corporation. This company was founded in 2012 and operates from its base in Beverly Hills, California.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms